title: Hepatic glucose and lipid metabolism.
abstract: The liver has a central role in the regulation of systemic glucose and lipid fluxes during feeding and fasting and also relies on these substrates for its own energy needs. These parallel requirements are met by coordinated control of carbohydrate and lipid fluxes into and out of the Krebs cycle, which is highly tuned to nutrient availability and heavily regulated by insulin and glucagon. During progression of type 2 diabetes, hepatic carbohydrate and lipid biosynthesis fluxes become elevated, thus contributing to hyperglycaemia and hypertriacylglycerolaemia. Over this interval there are also significant fluctuations in hepatic energy state. To date, it is not known to what extent abnormal glucose and lipid fluxes are causally linked to altered energy states. Recent evidence that the glucose-lowering effects of metformin appear to be mediated by attenuation of hepatic energy generation places an additional spotlight on the interdependence of hepatic biosynthetic and oxidative fluxes. The transition from fasting to feeding results in a significant re-direction of hepatic glucose and lipid fluxes and may also incur a temporary hepatic energy deficit. At present, it is not known to what extent these variables are additionally modified by type 2 diabetes and/or non-alcoholic fatty liver disease. Thus, there is a compelling need to measure fluxes through oxidative, gluconeogenic and lipogenic pathways and determine their relationship with hepatic energy state in both fasting and fed conditions. New magnetic resonance-based technologies allow these variables to be non-invasively studied in animal models and humans. This review summarises a presentation given at the symposium entitled 'The liver in focus' at the 2015 annual meeting of the EASD. It is accompanied by two other reviews on topics from this symposium (by Kenneth Cusi, DOI: 10.1007/s00125-016-3952-1 , and by Hannele Yki-Järvinen, DOI: 10.1007/s00125-016-3944-1 ) and a commentary by the Session Chair, Michael Roden (DOI: 10.1007/s00125-016-3911-x ).
authors.affiliation: Metabolic Control Group, Center for Neurosciences and Cell Biology of Coimbra, UC Biotech, Biocant Park, 3060-197, Cantanhede, Portugal. john.griffith.jones@gmail.com.|APDP-Diabetes Portugal-Education and Research Center (APDP-ERC), Lisbon, Portugal. john.griffith.jones@gmail.com.
authors.forename: John G
authors.initials: JG
authors.lastname: Jones
mesh_terms: D002952:Citric Acid Cycle / Q000502:physiology; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D050356:Lipid Metabolism / Q000502:physiology; D008099:Liver / Q000378:metabolism*; D009682:Magnetic Resonance Spectroscopy
chemical_list: D005947:Glucose
keywords: 13C Isotopomer analysis; Anaplerosis; De novo lipogenesis; Deuterated water; Krebs cycle; Magnetic resonance spectroscopy; Pyruvate cycling; Review